When the doctor’s wife had a small baby, he had a vision that the baby would have no chance of surviving without his care.
He started a Facebook page to promote his vision.
By the end of April, more than 50,000 people had signed up.
He had raised nearly $1 million.
But, like many in the medical field, he also began to wonder what the long-term consequences would be.
As a surgeon, he’d always been cautious about prescribing drugs that could cause side effects.
But his initial reaction was to see if he could find a better alternative.
“When you’re an obstetrician and you’re doing surgery, you know, I’ve been there and done that,” he said.
The surgeon went to a hospital in North Carolina, where he saw an obstetrical resident who offered him a pill that would treat the virus, but would not kill it. “
I started to realize I could use a little bit more caution in the treatment of my patients, and I had an epiphany when I was in the hospital.”
The surgeon went to a hospital in North Carolina, where he saw an obstetrical resident who offered him a pill that would treat the virus, but would not kill it.
The patient said he was very excited about the new drug, but that it was still not approved by the Food and Drug Administration.
“That was really shocking to me,” the surgeon said.
He went back to the doctor and told him about the possibility of using the drug.
“He said, ‘You’ve gotta go back to a doctor,’ and I said, OK, I’ll do that,” the doctor recalled.
“The next morning, we were in the operating room, and they told us that there was a possibility that we would have to discontinue the pill.”
But the surgeon went ahead and continued prescribing it anyway.
Within weeks, the virus was gone, but his patient was still on the pill.
The doctor also became increasingly concerned that he was not doing enough to keep patients on the drug, because the side effect was so bad.
“You see these patients who are on the treatment who come in and they just stop, and that’s just heartbreaking,” the patient said.
As the doctors began to worry about patients who were in a vegetative state, he began to see a pattern emerging.
“We were getting people that were not even aware of the risk, or the possibility, of getting sick,” he recalled.
They were also finding that the virus could spread to the fetus, but were not reporting that to their doctors.
The hospital began to notice the side impact of the drug: The patient began getting headaches and nausea, and some of the patients stopped seeing the surgeon.
“What’s happening is that we’re losing patients and losing revenue and losing money, which is not a good outcome,” the hospital’s chief executive said.
The surgeon and his wife were concerned that they were losing patients to the virus.
So they started thinking about ways to stop it.
After several months of discussion with their hospital’s leadership, the surgeon and wife decided to look into creating a nonprofit organization to help patients who could not be cured by the drug they were using.
They asked the hospital to consider allowing the drug to be used in a patient-controlled manner, which would allow patients to have access to it if they were in good health and did not need to go into a hospital.
The medical center, which has been in business for more than 40 years, did not initially consider the idea.
“Our first thought was, ‘What is the right thing to do?’,” said the surgeon, who asked that his last name not be used.
“But then we started to think about the impact of this, and what we can do about it.”
The idea of a nonprofit group to help people who could no longer be cured became an immediate reality.
The surgical center partnered with a private hospital in New York, which now has more than 100 residents who have been given the drug because they’ve been treated with it.
About 60% of the group’s patients are on it, and it has become the go-to place for those who have had other surgeries and have become infected.
But the hospital is also using it as a way to help educate patients about what they’re supposed to do when they see their doctor.
“Some of them may be thinking, ‘Why should I go to a clinic?
Is this something I can do in my own home?'” said the hospital president, who was not involved in the effort to create a nonprofit.
The surgeons hope to help other hospitals in the U.S. follow suit.
“This is a game-changer,” the president said.
Some hospitals are beginning to see how effective this treatment can be, said the president.
“There are a lot of people who have not seen a surgeon who is on this drug and it’s making a difference